Research Nester published a report titled “Candidiasis Drugs Market: Global Demand Analysis & Opportunity Outlook 2030” which delivers detailed overview of the global candidiasis drugs market in terms of market segmentation by disease type, drug type, end-user, and by region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
The global candidiasis drugs market is anticipated to attain a CAGR of ~6% over the forecast period, i.e., 2022 – 2030. The market is segmented on the basis of disease type into oral, vaginal, cutaneous, invasive, and others, out of which, the vaginal segment is anticipated to gain a notable share over the forecast period. The growth of the segment can be attributed to the high prevalence of vaginal candidiasis, especially among women living in low-income countries. It is often misunderstood that vaginal candidiasis is sexually transmitted, while it actually spread due to poor intimate hygiene. According to the data by the Center for Disease Control and Prevention (CDC), about 20% women do not notice any symptoms of candidiasis.
The global candidiasis drugs market is estimated to grow on the back of increasing prevalence of candidiasis, backed by rising cases of diabetes. High level of glucose in blood promotes the activation of candida. The rising incidences of diabetes is estimated to boost the market growth. According to the report by the World Health Organization (WHO), 422 million people worldwide suffer from diabetes. The increasing health awareness amongst people, easy availability of anti-fungal drugs, and growing investment in research and development of new drugs, are estimated to boost the market growth.
Download Sample of This Strategic [email protected] https://www.researchnester.com/sample-request-3650
On the basis of geographical analysis, the global candidiasis drugs market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in the North America region is anticipated to gain the largest market share throughout the forecast period on the back of the constantly rising cases of candidiasis. As per a report by the CDC, approximately 25,000 people suffer from candidiasis in the United States each year. Presence of major pharmaceutical companies, and efficient healthcare system in the region, are expected to boost the market growth.
The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.
Growing Cases of Candidiasis to Boost the Market Growth
Candidiasis is a type of yeast infection, caused by fungus candida. This fungus is present inside the human body, and it’s out of control growth causes candidiasis. Hot and humid climate, poor personal hygiene, and high blood sugar are the primary causes of candidiasis.
Download/Request Sample Copy of Strategic Report: https://www.researchnester.com/sample-request-3650
However, lack of health awareness amongst people is expected to operate as key restraint to the growth of the global candidiasis drugs market over the forecast period.
This report also provides the existing competitive scenario of some of the key players of the global candidiasis drugs market which includes company profiling of Pfizer Inc., Glenmark Pharmaceuticals, Merck KGaA, Novartis AG, Sanofi-aventis Groupe, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Daiichi Sankyo Company, Limited, Siemens Healthcare GmbH and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global candidiasis drugs market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
About Research Nester
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.
Contact for more Info:
Email: [email protected]
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919